Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Atypical benign partial epilepsy, also known as the pseudo-lennox syndrome, is categorized as a condition with an onset between two and six years of age, as well as the occurrence of partial motor seizures, centrotemporal spikes, atypical absences, and myoclonic-atonic seizures. Normal neurological and mental function persists throughout the course of the seizures. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Atypical Benign Partial Epilepsy below!
For more information on how to use Laverne, please read the How to Guide.
We have 461 products for the study of Atypical Benign Partial Epilepsy that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.